Variant report

Variant	nsv615638
Chromosome Location	chr9:136498143-136505241
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:39)
CpG islands
(count:427)
Chromatin interactive
region (count:2)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:39 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTCF	chr9:136501440-136501590	SK-N-SH_RA	brain:	n/a	n/a
2	CTCF	chr9:136504860-136505010	Hela-S3	cervix:	n/a	n/a
3	CTCF	chr9:136498000-136498150	SK-N-SH_RA	brain:	n/a	n/a
4	CTCF	chr9:136502620-136502770	SK-N-SH_RA	brain:	n/a	n/a
5	CTCF	chr9:136498020-136498170	SK-N-SH_RA	brain:	n/a	n/a
6	CTCF	chr9:136500660-136500810	SK-N-SH_RA	brain:	n/a	n/a
7	EP300	chr9:136501003-136501593	SK-N-SH_RA	brain:	n/a	chr9:136501313-136501320
8	EP300	chr9:136500223-136500521	SK-N-SH_RA	brain:	n/a	n/a
9	EP300	chr9:136496722-136504328	SK-N-SH	brain:	n/a	chr9:136503169-136503185 chr9:136499746-136499762 chr9:136501313-136501320 chr9:136497018-136497034 chr9:136499140-136499150
10	EP300	chr9:136498038-136498356	SK-N-SH_RA	brain:	n/a	n/a
11	EP300	chr9:136498397-136498620	SK-N-SH_RA	brain:	n/a	n/a
12	EP300	chr9:136500914-136501631	SK-N-SH_RA	brain:	n/a	chr9:136501313-136501320
13	EP300	chr9:136498075-136498359	SK-N-SH_RA	brain:	n/a	n/a
14	GABPA	chr9:136502721-136503336	H1-hESC	embryonic stem cell:	n/a	n/a
15	GATA2	chr9:136500996-136501527	SH-SY5Y	brain:	n/a	chr9:136501174-136501181
16	GATA2	chr9:136498862-136499440	SH-SY5Y	brain:	n/a	n/a
17	GATA2	chr9:136497880-136498383	SH-SY5Y	brain:	n/a	chr9:136498198-136498207
18	JUND	chr9:136502942-136503115	H1-hESC	embryonic stem cell:	n/a	n/a
19	MAFK	chr9:136499059-136499168	K562	blood:	n/a	n/a
20	MAX	chr9:136502963-136503365	H1-hESC	embryonic stem cell:	n/a	chr9:136503189-136503199
21	MXI1	chr9:136500841-136504397	SK-N-SH	brain:	n/a	chr9:136501462-136501471 chr9:136502239-136502248
22	MXI1	chr9:136496535-136499781	SK-N-SH	brain:	n/a	n/a
23	MYC	chr9:136502164-136502261	MCF-7	breast:	n/a	chr9:136502250-136502259
24	PBX3	chr9:136501097-136501570	SK-N-SH	brain:	n/a	n/a
25	POLR2A	chr9:136501045-136501726	SK-N-SH	brain:	n/a	n/a
26	POLR2A	chr9:136501076-136501640	SK-N-SH	brain:	n/a	n/a
27	POLR2A	chr9:136498027-136498427	H1-neurons	neurons:	n/a	n/a
28	RAD21	chr9:136500975-136501443	SK-N-SH_RA	brain:	n/a	n/a
29	REST	chr9:136497848-136498388	SK-N-SH	brain:	n/a	n/a
30	REST	chr9:136500982-136501824	SK-N-SH	brain:	n/a	chr9:136501240-136501249 chr9:136501083-136501103 chr9:136501442-136501456 chr9:136501085-136501095
31	TCF12	chr9:136500932-136501704	SK-N-SH	brain:	n/a	chr9:136501337-136501347
32	TEAD4	chr9:136501081-136501536	SK-N-SH	brain:	n/a	n/a
33	UBTF	chr9:136499321-136499554	K562	blood:	n/a	n/a
34	UBTF	chr9:136502964-136503034	K562	blood:	n/a	n/a
35	UBTF	chr9:136503169-136503193	K562	blood:	n/a	n/a
36	USF1	chr9:136500992-136501304	SK-N-SH_RA	brain:	n/a	n/a
37	YY1	chr9:136501057-136501865	SK-N-SH_RA	brain:	n/a	n/a
38	YY1	chr9:136501090-136501684	SK-N-SH_RA	brain:	n/a	n/a
39	ZNF263	chr9:136500129-136500653	HEK293-T-REx	kidney:	n/a	chr9:136500378-136500399

(count:427 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:136501420-136501470	HL-60	blood:	n/a
2	chr9:136501784-136501834	SK-N-SH_RA	brain:	n/a
3	chr9:136500234-136500284	AoSMC	blood vessel:	n/a
4	chr9:136503185-136503235	K562	blood:	n/a
5	chr9:136501784-136501834	NB4	blood:	n/a
6	chr9:136501784-136501834	Caco-2	colon:	n/a
7	chr9:136503185-136503235	PFSK-1	brain:	n/a
8	chr9:136500855-136500905	Hepatocyte	liver:	n/a
9	chr9:136501784-136501834	MCF-7	breast:	n/a
10	chr9:136499189-136499239	MCF-7	breast:	n/a
11	chr9:136501772-136501822	GM19239	blood:	n/a
12	chr9:136499189-136499239	AG04450	lung:	fetal
13	chr9:136501420-136501470	HRE	kidney:	n/a
14	chr9:136500234-136500284	HPAEpiC	pulmonary alveolar:	n/a
15	chr9:136499189-136499239	HRE	kidney:	n/a
16	chr9:136500234-136500284	HepG2	liver:	n/a
17	chr9:136503185-136503235	MCF10A-Er-Src	breast:	n/a
18	chr9:136500855-136500905	HRE	kidney:	n/a
19	chr9:136500855-136500905	LNCaP	prostate:	n/a
20	chr9:136500855-136500905	HAEpiC	amniotic membrane:	n/a
21	chr9:136503185-136503235	AG04450	lung:	fetal
22	chr9:136501772-136501822	HUVEC	blood vessel:	n/a
23	chr9:136499189-136499239	HCPEpiC	choroid plexus:	n/a
24	chr9:136500855-136500905	ProgFib	skin:	n/a
25	chr9:136501420-136501470	Hela-S3	cervix:	n/a
26	chr9:136500855-136500905	AG04449	skin:	fetal
27	chr9:136501784-136501834	HL-60	blood:	n/a
28	chr9:136503185-136503235	HCM	heart:	n/a
29	chr9:136499189-136499239	NH-A	brain:	n/a
30	chr9:136503185-136503235	GM06990	blood:	n/a
31	chr9:136501772-136501822	AoSMC	blood vessel:	n/a
32	chr9:136501420-136501470	Jurkat	blood:	n/a
33	chr9:136499189-136499239	HIPEpiC	eye:	n/a
34	chr9:136500855-136500905	HMEC	breast:	n/a
35	chr9:136501420-136501470	ProgFib	skin:	n/a
36	chr9:136501784-136501834	GM19239	blood:	n/a
37	chr9:136499189-136499239	LNCaP	prostate:	n/a
38	chr9:136501420-136501470	HRPEpiC	eye:	n/a
39	chr9:136500855-136500905	SAEC	small airway:	n/a
40	chr9:136500234-136500284	K562	blood:	n/a
41	chr9:136500855-136500905	HIPEpiC	eye:	n/a
42	chr9:136500234-136500284	GM06990	blood:	n/a
43	chr9:136501420-136501470	HUVEC	blood vessel:	n/a
44	chr9:136501772-136501822	SK-N-SH	brain:	n/a
45	chr9:136499189-136499239	AoSMC	blood vessel:	n/a
46	chr9:136501784-136501834	HEEpiC	esophagus:	n/a
47	chr9:136500855-136500905	A549	lung:	n/a
48	chr9:136501772-136501822	HCPEpiC	choroid plexus:	n/a
49	chr9:136501772-136501822	RPTEC	kidney:	n/a
50	chr9:136499189-136499239	Hepatocyte	liver:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr9:136475965..136477693-chr9:136502084..136503686,2	MCF-7	breast:
2	chr9:136499615..136503712-chr9:136504144..136508485,4	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FAM163B-1	chr9:136498109-136498221	ENSG00000261018.1

No data

Variant related genes	Relation type
DBH	TF binding region
ENSG00000261018	TF binding region
DBH	CpG island
ENSG00000261018	CpG island
ENSG00000123454	chromatin interactions

Extended variants
information (count: 395 )
Associated
traits (count: 80 )

Variant overlapped rSNPs/rCNVs (count:395 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1076153	chr9:136498143-136498144	Enhancers Weak transcription Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs71505216	chr9:136498161-136498162	Enhancers Weak transcription Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs555976788	chr9:136498168-136498169	Enhancers Weak transcription Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
4	rs574258276	chr9:136498200-136498201	Enhancers Weak transcription Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
5	rs541578541	chr9:136498201-136498202	Enhancers Weak transcription Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
6	rs191152396	chr9:136498301-136498302	Enhancers Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
7	rs112037945	chr9:136498329-136498330	Enhancers Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
8	rs10993897	chr9:136498365-136498366	Enhancers Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
9	rs563333792	chr9:136498376-136498377	Enhancers Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
10	rs368431415	chr9:136498518-136498519	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
11	rs182126836	chr9:136498522-136498523	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
12	rs561983139	chr9:136498525-136498526	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
13	rs529197270	chr9:136498573-136498574	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
14	rs35008039	chr9:136498599-136498600	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs186019041	chr9:136498616-136498617	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
16	rs372364169	chr9:136498635-136498636	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
17	rs565918671	chr9:136498687-136498688	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
18	rs533052389	chr9:136498693-136498694	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
19	rs374016204	chr9:136498694-136498695	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
20	rs71503352	chr9:136498714-136498715	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
21	rs1076151	chr9:136498715-136498716	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs555082337	chr9:136498721-136498722	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
23	rs567918451	chr9:136498745-136498746	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
24	rs1076150	chr9:136498761-136498762	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
25	rs71505217	chr9:136498773-136498774	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs577856630	chr9:136498831-136498832	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
27	rs546703725	chr9:136498854-136498855	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
28	rs538743771	chr9:136498867-136498868	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
29	rs556995143	chr9:136498876-136498877	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
30	rs190536922	chr9:136498893-136498894	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
31	rs79325566	chr9:136498894-136498895	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
32	rs561155153	chr9:136498912-136498913	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
33	rs142828530	chr9:136498927-136498928	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
34	rs541009670	chr9:136498983-136498984	Enhancers Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
35	rs548688701	chr9:136499024-136499025	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs535306666	chr9:136499032-136499033	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs368225763	chr9:136499034-136499035	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
38	rs183414505	chr9:136499049-136499050	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
39	rs370200492	chr9:136499053-136499054	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
40	rs187714695	chr9:136499099-136499100	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
41	rs145476016	chr9:136499139-136499140	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
42	rs560159718	chr9:136499179-136499180	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
43	rs373814207	chr9:136499190-136499191	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
44	rs548940697	chr9:136499206-136499207	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
45	rs368825383	chr9:136499211-136499212	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
46	rs532131241	chr9:136499213-136499214	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
47	rs201526338	chr9:136499230-136499231	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
48	rs149299687	chr9:136499232-136499233	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
49	rs191033627	chr9:136499234-136499235	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
50	rs568769641	chr9:136499245-136499246	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:80)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Medulloblastoma	21979893	CNVD
microdeletion syndrome	16199537	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Urothelial carcinoma	21177765	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Myelofibrosis	22110671	CNVD
Leukemia	17361228	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Glioblastoma	16823260	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Non-small cell lung cancer	21044232	CNVD
Brain cancer	20823417	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Renal cell carcinoma	19461508	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Heart disease	21282601	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	17603634	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	18632612	CNVD
Cardiac fibroma	18329553	CNVD
Lung cancer	19147751	CNVD
Melanoma	18172304	CNVD
Cervical cancer	16585170	CNVD
Ependymoma	19289631	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Cervical cancer	17311676	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Gastric cancer	17908304	CNVD
Breast cancer	16608533	CNVD
Metanephric adenoma	20802469	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Chordoma	18071362	CNVD
small cell lung cancer	20016488	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Kleefstra Syndrome	21538692	CNVD
Disorders of sex development	22290220	CNVD
Cancer	21183584	CNVD
Chronic myelomonocytic leukemia	16760666	CNVD
Abnormal phenotypes	18644119	CNVD
Ovarian cancer	21720365	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Sudden cardiac death	19188705	CNVD
Myoepithelioma	18604193	CNVD
Tuberous sclerosis	19566914	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Breast cancer	21364760	CNVD
Cancer	20581869	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Breast cancer	21509527	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Hepatocellular carcinoma	22174799	CNVD
Bladder cancer	21909424	CNVD
Cancer	17160897	CNVD
Ependymoma	20639864	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	20932292	CNVD
Schizophrenia	21346763	CNVD
T-cell lymphomas	22341440	CNVD

Chromatin state (count:101 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:136494600-136498400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr9:136494600-136498800	Weak transcription	Fetal Brain Male	brain
3	chr9:136496400-136500800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr9:136496800-136498800	Weak transcription	Fetal Brain Female	brain
5	chr9:136496800-136501200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
6	chr9:136497200-136499800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
7	chr9:136497200-136501200	Enhancers	Fetal Thymus	thymus
8	chr9:136497400-136500800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
9	chr9:136497400-136501200	Bivalent Enhancer	Placenta	Placenta
10	chr9:136497800-136499000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
11	chr9:136497800-136500000	Enhancers	H9 Cell Line	embryonic stem cell
12	chr9:136497800-136500000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
13	chr9:136497800-136500600	Enhancers	Fetal Lung	lung
14	chr9:136497800-136500800	Enhancers	Brain Germinal Matrix	brain
15	chr9:136497800-136500800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
16	chr9:136498000-136499200	Enhancers	HUES48 Cell Line	embryonic stem cell
17	chr9:136498000-136499600	Enhancers	Thymus	Thymus
18	chr9:136498000-136499800	Enhancers	HUES6 Cell Line	embryonic stem cell
19	chr9:136498000-136500000	Enhancers	ES-I3 Cell Line	embryonic stem cell
20	chr9:136498000-136500000	Enhancers	iPS-18 Cell Line	embryonic stem cell
21	chr9:136498000-136500200	Enhancers	H1 Cell Line	embryonic stem cell
22	chr9:136498000-136500800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
23	chr9:136498000-136501000	Bivalent Enhancer	Fetal Muscle Leg	muscle
24	chr9:136498000-136501800	Bivalent Enhancer	Fetal Stomach	stomach
25	chr9:136498000-136501800	Enhancers	Spleen	Spleen
26	chr9:136498400-136499600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
27	chr9:136498400-136501400	Weak transcription	Right Atrium	heart
28	chr9:136498600-136499200	Enhancers	HUES64 Cell Line	embryonic stem cell
29	chr9:136498800-136499200	Enhancers	iPS-20b Cell Line	embryonic stem cell
30	chr9:136498800-136499400	Enhancers	Fetal Brain Female	brain
31	chr9:136498800-136499600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
32	chr9:136498800-136499800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
33	chr9:136498800-136500000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
34	chr9:136498800-136500200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
35	chr9:136498800-136500400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
36	chr9:136498800-136500400	Enhancers	Liver	Liver
37	chr9:136498800-136500800	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
38	chr9:136498800-136501800	Enhancers	Fetal Brain Male	brain
39	chr9:136499000-136499800	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
40	chr9:136499200-136499400	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
41	chr9:136499200-136499800	Enhancers	Lung	lung
42	chr9:136499200-136499800	Enhancers	Dnd41	blood
43	chr9:136499200-136500400	Enhancers	Primary hematopoietic stem cells	blood
44	chr9:136499200-136500800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
45	chr9:136499200-136502800	Weak transcription	HUES48 Cell Line	embryonic stem cell
46	chr9:136499200-136502800	Weak transcription	HUES64 Cell Line	embryonic stem cell
47	chr9:136499200-136503000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
48	chr9:136499400-136500400	Weak transcription	Fetal Brain Female	brain
49	chr9:136499400-136500600	Enhancers	Gastric	stomach
50	chr9:136499600-136500000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links